Research Article
Exploring the Impact of Medication Regimen Complexity on Health-Related Quality of Life in Patients with Multimorbidity
Table 2
EQ-5D-5L index and EQ-VAS score stratified by the level of medication regimen complexity.
| MRC category | n | EQ-5D-5L index | EQ-VAS score | Mean ± SD | Welch F | value | Games-Howell posthoc analysis: value (95% CI) | Mean ± SD | Welch F | value | Games-Howell posthoc analysis: value (95% CI) | Low complexity | Medium complexity | Low complexity | Medium complexity |
| Low complexity | 09 | 0.85 ± 0.08 | 8.71 | 0.001 | | | 81.67 ± 6.61 | 7.88 | 0.002 | | | Medium complexity | 169 | 0.79 ± 0.14 | | | 0.229 (−0.03–0.14) | | 79.24 ± 10.87 | | | 0.575 (−3.99–8.85) | | High complexity | 238 | 0.74 ± 0.15 | | | 0.003 (0.01–0.09) | 0.017 (0.18–0.28) | 75.30 ± 11.85 | | | 0.002 (1.29–6.63) | 0.05 (−0.01–12.78) |
|
|
CI: confidence interval; EQ‐5D‐5L: euroqol-five dimensions five-levels; EQ‐VAS: euroqol-visual analogue scale MRC: medication regimen complexity; SD: standard deviation.
|